Not Available
Society for Pediatric Radiology – Poster Archive
Final ID: Poster #: EDU-005
Dynamic Contrast-Enhanced MR Lymphangiography in Infants: How We Do It
Purpose or Case Report: Dynamic contrast-enhanced MR lymphangiography (DCEMRL) with intranodal injection has emerged as a useful tool in evaluating lymphatic disorders. We share our institutional experience with DCEMRL in infants through a detailed discussion of technique and series of case presentations.
Techniques for nodal access and imaging infants with DCEMRL are explained through text and step-by-step illustrations.
MR lymphangiography images of infants between 22 days and 8 weeks of age are presented with multi-modality correlation, including patients with congenital chylous ascites, non-immune fetal hydrops, and postsurgical chylothorax. Each case discussion includes a review of relevant lymphatic anatomy, explanation of the disease process, and key teaching points regarding DCEMRL in infants.
Methods & Materials:
Results:
Conclusions:
Techniques for nodal access and imaging infants with DCEMRL are explained through text and step-by-step illustrations.
MR lymphangiography images of infants between 22 days and 8 weeks of age are presented with multi-modality correlation, including patients with congenital chylous ascites, non-immune fetal hydrops, and postsurgical chylothorax. Each case discussion includes a review of relevant lymphatic anatomy, explanation of the disease process, and key teaching points regarding DCEMRL in infants.
Methods & Materials:
Results:
Conclusions:
More abstracts on this topic:
Pediatric Moyamoya Disease: Role of Imaging in Diagnosis and Clinical Decision Making
Patel Hanisha, Mayl Jonathan, Maheshwari Mohit, Mohan Suyash, Chandra Tushar
Serum biochemical markers to predict radiologic metabolic bone disease in preterm infantYou Sun Kyoung, Lee So Mi, Cho Hyun-hae
Poster____EDU-005.pdf
Comments
We encourage you to join the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and stimulate conversation and knowledge sharing.
Please click here to review the full terms and conditions for engaging in the discussion, including refraining from product promotion and non-constructive feedback.
You have to be authorized to post a comment. Please,
Login or
Signup.
Please note that this is a separate login, not connected with your credentials used for the SPR main website.
Rate this abstract
(Maximum characters: 500)
Please note that this is a separate login, not connected with your credentials used for the SPR main website.